ScholarWorks@Korea University: Kim, Woo Joo

Detailed Information

Kim, Woo Joo (김우주)

Department of Biomedical Sciences

Research Area

Tel 구3051
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

COVID19:12||Influenza:11||SARSCoV2:9||Korea:5||Epidemiology:4||Republic of Korea:3||Streptococcus pneumoniae:3||influenza:3||immunogenicity:3||influenza vaccine:3||Pandemic:3||Vaccine:3||Vaccination:3||antiviral agents:2||Seroprevalence:2||Effectiveness:2||influenza A virus:2||Influenza vaccine:2||Rapid diagnostic test:2||Safety:2||Human immunodeficiency virus:2||Mortality:2||influenzalike illness:2||opsonophagocytic killing assay:2||Hospitalization:2||HIV:2||Adult:2||Pneumococcal infections:2||surveillance:2||Streptococcus agalactiae:2||immunoassay:2||대유행:2||Virus culture:2||Hantaan virus:2||Hantavirus:2||epidemiology:2||Middle East Respiratory Syndrome:2||Case fatality rate:1||death:1||Low birth weight:1||Obesity:1||hospitalbased influenza morbidity and mortality (HIMM):1||H7N9 Virus:1||adults:1||burden of disease:1||corticosteroid:1||influenza vaccines:1||Hepatitis A virus:1||MF59 adjuvant:1||intramuscular:1||safety:1||MULTIRESISTANT ACINETOBACTER:1||PCR:1||Management:1||인플루엔자:1||humoral immunity:1||Communityacquired pneumonia:1||Pneumococcus:1||Ageusia:1||Health personnel:1||matrix metalloproteinase13:1||Surveillance:1||Liver Cirrhosis:1||HIV transmission network:1||Cellular immunity:1||severe dengue:1||cell culture techniques:1||Health survey:1||RSV RDT PCR:1||Quadrivalent meningococcal vaccine:1||screening tool:1||Physician:1||Etiology:1||elderly:1||Pneumococcal infection:1||Casecontrol study:1||Influenza A/B:1||Human:1||Small bowel:1||Novel influenza:1||Perspective:1||Infected aortic aneurysm:1||inhalation:1||mortality:1||Communicable diseases:1||Middle East respiratory syndrome coronavirus:1||Hospital planning:1||atherosclerosis:1||Anxiety:1||antiretrovirus drug:1||human immunodeficiency virus:1||AsiaPacific:1||vaccine mismatch:1||Influenza B virus:1||phylogenetic analysis:1||Campylobacter:1||Cohort Study:1||H5N1:1||Incubation period:1||Pandemic influenza:1||HIVassociated neurocognitive disorder (HAND):1||Health surveys:1||Children:1||unprocessed:1||Pneumococcal vaccines:1||neuraminidase:1||VIRUS:1||ADULTS:1||Outbreaks:1||severe acute respiratory coronavirus 2:1||Control:1||Asymptomatic infection:1||Saliva:1||Viral Load:1||Ritonavir:1||Preterm birth:1||healthcare cost:1||pneumonia:1||HIV Infection:1||Dyslipidemia:1||Influenza A(H7N9) virus:1||hemophagocyticlymphohistiocytosis:1||human Influenza:1||clinical trial:1||influenza B virus:1||Outbreak control:1||Acinetobacter baumannii:1||Respiratory virus:1||Cost of illness:1||health education:1||oseltamivir:1||METALLOBETALACTAMASE:1||CARBAPENEM RESISTANCE:1||emerging:1||Incidence:1||Pneumococcal conjugate vaccine:1||Lopinavir:1||Pregnancy:1||literature review:1||seasonality:1||inactivated influenza vaccine:1||HIV1 env V3 sequence:1||Acute Respiratory Illness:1||inactivated:1||Coronavirus:1||H5N1 vaccine:1||intradermal:1||Specificity:1||RECOMMENDATIONS:1||Mucormycosis:1||Clostridium septicum:1||대책:1||Adverse Event:1||Risk factors:1||physical activity:1||Antigenic determinants:1||influenza B:1||Influenzalike Illness:1||quadrivalent influenza vaccine:1||Protease Inhibitor:1||human:1||epidemics:1||Neisseria meningitidis:1||neuropsychological tests:1||risk factors:1||Awareness:1||molecular:1||Chronic cardiovascular disease:1||Chronic respiratory disease:1||Pandemics:1||CHILDREN:1||Acute myeloid leukemia:1||Colon cancer:1||인플루엔자 A (H1N1):1||신종인플루엔자:1||cellular immunity:1||Social Distancing:1||p38 mitogenactivated protein kinase:1||Hydroxychloroquine:1||Cardiovascular disease:1||Depressive disorder:1||effectiveness:1||receptor:1||substitution:1||molecular characterization:1||CD4+ Lymphocyte Count:1||Countermeasures:1||AS03:1||Korean adults:1||Biofilm:1||Antibacterial agents:1||Conjugate vaccines:1||Herpes zoster:1||diagnostic:1||Realtime RT PCR:1||Influenza vaccines:1||CLINAFLOXACIN:1||역학:1||치료:1||Strategy:1||Arthritis:1||Immunogenicity:1||Anosmia:1||immunity:1||Chlorhexidine:1||Coronavirus Disease 2019:1||vaccination:1||Acquired immunodeficiency syndrome:1||Pneumonia:1||pneumococcal vaccine:1||capsular polysaccharide:1||incidence:1||Bacteremia:1||South Korea:1||Metabolic Complication:1||DNA vaccine:1||dengue hemorrhagic fever:1||pandemic:1||vaccine:1||Reproduction number:1||drug resistance:1||Hemorrhagic fever with renal syndrome:1||pneumococcal vaccination:1||Sensitivity:1||Fluorescent immunoassay:1||Chemotherapy:1||GRAMNEGATIVE BACTERIA:1||PSEUDOMONASAERUGINOSA:1||CLINICAL STRAINS:1||EFFLUX PUMP:1||EXPRESSION:1||Influenza A (H1N1):1||longevity:1||Closecontact transmission:1||ciclesonide:1||Disease outbreaks:1||Infection control:1||Seroepidemiology:1||GBS:1||group B streptococcus:1||

STATISTICS: Total View :6,964,977; Today View :471

RSS_1.0 RSS_2.0 ATOM_1.0

145 Anam-ro, Seongbuk-gu, Seoul, 02841, Korea+82-2-3290-2963

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE